rs553283319

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The ENST00000308370.11(LTBP4):​c.415A>G​(p.Arg139Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000208 in 1,103,782 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.000021 ( 0 hom. )

Consequence

LTBP4
ENST00000308370.11 missense

Scores

5
14

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.397

Publications

1 publications found
Variant links:
Genes affected
LTBP4 (HGNC:6717): (latent transforming growth factor beta binding protein 4) The protein encoded by this gene binds transforming growth factor beta (TGFB) as it is secreted and targeted to the extracellular matrix. TGFB is biologically latent after secretion and insertion into the extracellular matrix, and sheds TGFB and other proteins upon activation. Defects in this gene may be a cause of cutis laxa and severe pulmonary, gastrointestinal, and urinary abnormalities. Three transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, May 2010]
LTBP4 Gene-Disease associations (from GenCC):
  • cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), PanelApp Australia

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.11950484).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LTBP4NM_001042544.1 linkc.415A>G p.Arg139Gly missense_variant Exon 4 of 33 NP_001036009.1 Q8N2S1-1B3KXY6
LTBP4NM_003573.2 linkc.304A>G p.Arg102Gly missense_variant Exon 4 of 33 NP_003564.2 Q8N2S1A0A0C4DH07B3KXY6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LTBP4ENST00000308370.11 linkc.415A>G p.Arg139Gly missense_variant Exon 4 of 33 1 ENSP00000311905.8 Q8N2S1-1
LTBP4ENST00000204005.13 linkc.304A>G p.Arg102Gly missense_variant Exon 4 of 33 1 ENSP00000204005.10 A0A0C4DH07
LTBP4ENST00000593738.1 linkn.158A>G non_coding_transcript_exon_variant Exon 1 of 2 3

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.0000208
AC:
23
AN:
1103782
Hom.:
0
Cov.:
31
AF XY:
0.0000210
AC XY:
11
AN XY:
522588
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
23088
American (AMR)
AF:
0.00
AC:
0
AN:
8590
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
14482
East Asian (EAS)
AF:
0.00
AC:
0
AN:
26630
South Asian (SAS)
AF:
0.00
AC:
0
AN:
21754
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
36780
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4204
European-Non Finnish (NFE)
AF:
0.0000249
AC:
23
AN:
924150
Other (OTH)
AF:
0.00
AC:
0
AN:
44104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000264

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Feb 24, 2015
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.Arg139Gly variant in LTBP4 has not been previously reported in individuals with pulmonary disease. Data from large population studies is insufficient to a ssess the frequency of this variant. Computational prediction tools and conserva tion analysis do not provide strong support for or against an impact to the prot ein. In summary, the clinical significance of the p.Arg139Gly variant is uncerta in. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Uncertain
0.020
T
BayesDel_noAF
Benign
-0.21
CADD
Benign
22
DANN
Uncertain
0.99
DEOGEN2
Benign
0.044
T;T
Eigen
Benign
-0.49
Eigen_PC
Benign
-0.31
FATHMM_MKL
Benign
0.26
N
LIST_S2
Benign
0.66
T;T
M_CAP
Uncertain
0.096
D
MetaRNN
Benign
0.12
T;T
MetaSVM
Benign
-0.80
T
MutationAssessor
Benign
0.0
.;N
PhyloP100
0.40
PrimateAI
Uncertain
0.76
T
PROVEAN
Benign
0.080
N;N
REVEL
Benign
0.25
Sift
Benign
0.20
T;D
Sift4G
Uncertain
0.024
D;D
Polyphen
0.0020
.;B
Vest4
0.37
MVP
0.62
MPC
1.0
ClinPred
0.40
T
GERP RS
3.5
Varity_R
0.23
gMVP
0.57
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs553283319; hg19: chr19-41106047; API